Related Experiment Video
Updated: Dec 5, 2025

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
Published on: April 19, 2024
Bromelain: A Review on its Potential as a Therapy for the Management of Covid-19
B V Owoyele1, A O Bakare2, M O Ologe3
1Department of Physiology, University of Ilorin. deleyele@yahoo.com.
Abstract:
Coronavirus Disease 2019 is a wide-spreading severe viral disease caused by the Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-COV-2) virus that needs to be urgently eradicated. SARS-COV-2 has infected millions of people worldwide and results in more than three hundred thousand deaths. Several repurposed drugs have failed to successfully eradicate the infection. Multiorgan failure caused by pronounced inflammation and systemic coagulation accounts for severe complications and death associated with diseases. Bromelain appears to be a potential candidate that may be used to inhibit or prevent the symptoms of the diseases. Its anti-inflammatory and anticoagulatory properties make it a potential agent that may slow the progression of the disease. In this review, we highlighted the beneficial effects of bromelain based on both experimental and clinical evidence that make bromelain a good candidate for the treatment of symptoms of CoVID-19 infection.
Insights
Bromelain shows potential for treating Coronavirus Disease 2019 (COVID-19) symptoms. Its anti-inflammatory and anticoagulatory properties may help manage severe illness progression.
Area of Science:
- Virology
- Immunology
- Pharmacology
Background:
- Coronavirus Disease 2019 (COVID-19), caused by SARS-COV-2, is a severe global health crisis.
- High mortality rates are linked to severe inflammation and systemic coagulation.
- Existing treatments, including repurposed drugs, have shown limited success.
Purpose of the Study:
- To review the potential therapeutic benefits of bromelain for COVID-19 symptoms.
- To evaluate bromelain's anti-inflammatory and anticoagulatory properties in the context of COVID-19.
Main Methods:
- Literature review of experimental and clinical evidence.
- Analysis of bromelain's pharmacological effects.
Main Results:
- Bromelain exhibits significant anti-inflammatory properties.
- Bromelain demonstrates anticoagulatory effects.
- Evidence suggests bromelain may inhibit or prevent COVID-19 symptoms.
Conclusions:
- Bromelain is a promising candidate for managing COVID-19 symptoms.
- Its properties may help slow disease progression and reduce complications.
- Further clinical investigation into bromelain for COVID-19 is warranted.
More Related Videos
07:36Analysis of Raw and Processed Cyperi Rhizoma Samples Using Liquid Chromatography-Tandem Mass Spectrometry in Rats with Primary Dysmenorrhea
Published on: December 23, 2022
06:05Enema of Traditional Chinese Medicine for Patients with Severe Acute Pancreatitis
Published on: January 27, 2023
Related Concept Videos
Myocarditis III: Medical Management
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Acute Pancreatitis II: Clinical Manifestations and Management
Tonsillitis II: Management
Chronic Pancreatitis II: Collaborative Care
Assessment:
Cystic Fibrosis: Management
Sinus disease and chronic...